Home › Galapagos, GSK successfully conclude phase 2a study of skin disease drug
 

Keywords :   


Galapagos, GSK successfully conclude phase 2a study of skin disease drug

2014-04-17 09:46:53| Biotech - Topix.net

Belgian biotech group Galapagos NV on Thursday said it has successfully concluded the phase 2a study of a skin disease drug it is developing with Britain's GlaxoSmithKline PLC.

Tags: study skin drug phase

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.05ELF Beauty Teams with Billie Jean King to Change the Board Game to Support Inclusivity
05.05Target Faces Lawsuit Over Sunscreen Coral Bleaching Claims
05.05Goops Latest Launch & Hain Celestial Streamlines Portfolio
05.05The Summer of Sister Golden Hair
05.05Persil Laundry Detergent Rebrands
05.05Weekly Recap: Carefree Adds Pads to Lineup, Soft N Dry Secures Private Label Sales Network ...
05.05How Brexit is not 'done' for Northern Ireland
05.05Is Zimbabwe zigzagging into further currency chaos?
More »